EXTH-57. PLASMA AND CEREBROSPINAL FLUID PHARMACOKINETICS OF THE PROCASPASE-ACTIVATING COMPOUND, PAC-1, FOLLOWING ORAL ADMINISTRATION IN A NON-HUMAN PRIMATE MODEL

Eitemau Tebyg

• EXTH-25. THE CSF PENETRATION OF THE PROCASPASE-ACTIVATING COMPOUND (PAC-1) IN COMBINATION WITH TEMOZOLOMIDE (TMZ) IN A NONHUMAN PRIMATE CSF ACCESS MODEL
  gan: Lester McCully, Cynthia, et al.
  Cyhoeddwyd: (2020)
• EXTH-02. PLASMA AND CEREBROSPINAL FLUID PHARMACOKINETICS OF 5-AZACYTIDINE ALONE AND IN COMBINATION WITH INULIN IN A NON-HUMAN PRIMATE MODEL
  gan: McCully, Cynthia Lester, et al.
  Cyhoeddwyd: (2017)
• Plasma and cerebrospinal fluid pharmacokinetics of the Akt inhibitor, perifosine, in a non‑human primate model
  gan: Cole, Diane E., et al.
  Cyhoeddwyd: (2015)
• EXTH-65. PLASMA AND CEREBROSPINAL FLUID PHARMACOKINETICS COMPARISON OF BRAF AND MEK INHIBITORS FOLLOWING SINGLE AND EXTENDED ADMINISTRATION IN A PRE-CLINICAL NON-HUMAN PRIMATE MODEL
  gan: Lester McCully, Cynthia, et al.
  Cyhoeddwyd: (2019)
• HG-36 PLASMA AND CEREBROSPINAL FLUID (CSF) PHARMACOKINETICS OF PANOBINOSTAT FOLLOWING ORAL ADMINISTRATION TO NONHUMAN PRIMATES
  gan: Rodgers, Louis, et al.
  Cyhoeddwyd: (2016)